- Investing Ideas
- /
- Global Large Cap High Growth Potential
Global Large Cap High Growth Potential
Results
630
0 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
630 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
600760 | CN¥47.20 | 1.4% | 26.1% | CN¥130.1b | CN¥53.90 | PE52.9x | E29.4% | 0.6% | Capital Goods | ||
9992 | HK$104.70 | 1.5% | 492.2% | HK$138.9b | HK$97.74 | PE85.3x | E36.7% | 0.3% | Retail | ||
ONON | US$53.97 | -7.5% | 80.1% | US$17.8b | US$62.62 | PE125.2x | E29.7% | n/a | Consumer Durables | ||
NVDA | US$132.80 | 11.9% | 84.1% | US$3.3t | US$172.08 | PE51.6x | E21.6% | 0.03% | Semiconductors | ||
RHM | €731.40 | -3.5% | 100.4% | €31.8b | €773.71 | PE46.4x | E30.5% | 0.8% | Capital Goods | ||
ARES | US$186.37 | -4.6% | 38.1% | US$59.5b | US$198.36 | PE85.3x | E41.6% | 2.4% | Diversified Financials | ||
ALNY | US$268.99 | -0.7% | 66.0% | US$35.3b | US$299.74 | PS16.6x | E56.7% | n/a | Pharmaceuticals & Biotech | ||
300308 | CN¥111.50 | -2.9% | 22.9% | CN¥123.2b | CN¥192.85 | PE26.6x | E33.3% | 0.3% | Tech | ||
NU | US$13.94 | 4.8% | 40.5% | US$67.1b | US$15.06 | PB8.8x | E24.9% | n/a | Banks | ||
A196170 | ₩378,000.00 | 1.1% | 336.5% | ₩20.1t | ₩565,000.00 | PS270.9x | E140.6% | n/a | Pharmaceuticals & Biotech | ||
300502 | CN¥115.55 | -8.1% | 110.5% | CN¥81.9b | CN¥161.36 | PE43x | E36.6% | 0.1% | Tech | ||
ALAB | US$92.04 | -9.5% | n/a | US$16.4b | US$122.53 | PS36.8x | E64.3% | n/a | Semiconductors | ||
2345 | NT$738.00 | -2.8% | 34.7% | NT$432.0b | NT$789.38 | PE42.4x | E25.1% | 1.4% | Tech | ||
600989 | CN¥16.81 | -4.1% | 19.1% | CN¥123.3b | CN¥21.74 | PE19.6x | E38.5% | 1.7% | Materials | ||
BAM | CA$79.51 | -2.8% | 49.6% | CA$133.0b | CA$73.97 | PE199.6x | E87.6% | 2.7% | Diversified Financials | ||
ITCI | US$127.56 | 0.5% | 81.2% | US$13.5b | US$132.73 | PS22.1x | E52.9% | n/a | Pharmaceuticals & Biotech | ||
KSPI | US$95.49 | -2.1% | 8.9% | US$18.4b | US$131.43 | PE9.4x | E20.8% | 7.0% | Diversified Financials | ||
SMCI | US$38.61 | 32.4% | -51.2% | US$25.0b | US$40.79 | PE18.7x | E25.2% | n/a | Tech | ||
PME | AU$288.31 | -0.2% | 166.7% | AU$30.5b | AU$219.24 | PE363.9x | E22.7% | 0.2% | Healthcare | ||
SYM | US$29.14 | -3.8% | -33.3% | US$16.6b | US$34.32 | PS1.6x | E83.9% | n/a | Capital Goods | ||
BAJFINANCE | ₹8,191.20 | -3.4% | 24.0% | ₹5.1t | ₹8,607.85 | PE31.7x | E23.2% | 0.4% | Diversified Financials | ||
6669 | NT$2,225.00 | 6.2% | -1.8% | NT$413.5b | NT$3,015.59 | PE21.5x | E24.1% | 1.9% | Tech | ||
DIXON | ₹14,666.30 | -1.8% | 133.0% | ₹881.0b | ₹16,565.93 | PE111.5x | E25.8% | 0.03% | Consumer Durables | ||
500251 | ₹5,226.60 | -9.2% | 35.8% | ₹1.9t | ₹6,250.52 | PE96.1x | E23.4% | 0.06% | Retail |